BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15814280)

  • 1. The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients.
    Zheng HX; Zeevi A; McCurry K; Schuetz E; Webber S; Ristich J; Zhang J; Iacono A; Dauber J; McDade K; Zaldonis D; Lamba J; Burckart GJ
    Transpl Immunol; 2005 Mar; 14(1):37-42. PubMed ID: 15814280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism.
    Zheng H; Zeevi A; Schuetz E; Lamba J; McCurry K; Griffith BP; Webber S; Ristich J; Dauber J; Iacono A; Grgurich W; Zaldonis D; McDade K; Zhang J; Burckart GJ
    J Clin Pharmacol; 2004 Feb; 44(2):135-40. PubMed ID: 14747421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of pharmacogenomic factors on steroid dependency in pediatric heart transplant patients using logistic regression analysis.
    Zheng HX; Webber SA; Zeevi A; Schuetz E; Zhang J; Lamba J; Boyle GJ; Wilson JW; Burckart GJ
    Pediatr Transplant; 2004 Dec; 8(6):551-7. PubMed ID: 15598322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation.
    Zheng HX; Burckart GJ; McCurry K; Webber S; Ristich J; Iacono A; Dauber J; McDade K; Grgurich W; Zaldonis D; Pillage G; Griffith BP; Zeevi A
    J Heart Lung Transplant; 2004 May; 23(5):541-6. PubMed ID: 15135368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.
    Zhang X; Liu ZH; Zheng JM; Chen ZH; Tang Z; Chen JS; Li LS
    Clin Transplant; 2005 Oct; 19(5):638-43. PubMed ID: 16146556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
    Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
    Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MDR1/ABCB1 gene, a high-impact risk factor for cardiac transplant rejection.
    Barnard JB; Richardson S; Sheldon S; Fildes J; Pravica V; Hutchinson IV; Leonard CT; Yonan N
    Transplantation; 2006 Dec; 82(12):1677-82. PubMed ID: 17198259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
    Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
    Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 non-expressors.
    Wang J; Zeevi A; McCurry K; Schuetz E; Zheng H; Iacono A; McDade K; Zaldonis D; Webber S; Watanabe RM; Burckart GJ
    Transpl Immunol; 2006 Jan; 15(3):235-40. PubMed ID: 16431292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: a preliminary study.
    Yasui-Furukori N; Saito M; Nakagami T; Kaneda A; Tateishi T; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):286-91. PubMed ID: 16386826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipients.
    Barrera-Pulido L; Aguilera-García I; Docobo-Pérez F; Alamo-Martínez JM; Pareja-Ciuró F; Nuñez-Roldán A; Gómez-Bravo MA; Bernardos-Rodríguez A
    Transplant Proc; 2008 Nov; 40(9):2949-51. PubMed ID: 19010156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation.
    Jonsson JR; Hong C; Purdie DM; Hawley C; Isbel N; Butler M; Balderson GA; Clouston AD; Pandeya N; Stuart K; Edwards-Smith C; Crawford DH; Fawcett J; Powell EE
    Liver Transpl; 2001 Mar; 7(3):255-63. PubMed ID: 11244168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study.
    Girnita DM; Brooks MM; Webber SA; Burckart GJ; Ferrell R; Zdanowicz G; DeCroo S; Smith L; Chinnock R; Canter C; Addonizio L; Bernstein D; Kirklin JK; Ranganathan S; Naftel D; Girnita AL; Zeevi A
    Transplantation; 2008 Jun; 85(11):1632-9. PubMed ID: 18551071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 8 -251T>A and Interferon gamma +874A>T polymorphism: potential predictors of allograft outcome in renal transplant recipients from north India.
    Singh R; Kesarwani P; Ahirwar DK; Kapoor R; Mittal RD
    Transpl Immunol; 2009 May; 21(1):13-7. PubMed ID: 19189859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients.
    Masuda S; Goto M; Fukatsu S; Uesugi M; Ogura Y; Oike F; Kiuchi T; Takada Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2006 Jan; 79(1):90-102. PubMed ID: 16413244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of MDR1 single nucleotide polymorphisms C3435T and G2677T using real-time polymerase chain reaction: MDR1 single nucleotide polymorphism genotyping assay.
    Song P; Li S; Meibohm B; Gaber AO; Honaker MR; Kotb M; Yates CR
    AAPS PharmSci; 2002; 4(4):E29. PubMed ID: 12646001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients.
    Bandur S; Petrasek J; Hribova P; Novotna E; Brabcova I; Viklicky O
    Transplantation; 2008 Nov; 86(9):1206-13. PubMed ID: 19005401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients.
    Tada H; Tsuchiya N; Satoh S; Kagaya H; Li Z; Sato K; Miura M; Suzuki T; Kato T; Habuchi T
    Transplant Proc; 2005 May; 37(4):1730-2. PubMed ID: 15919447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistant 1 (MDR1) C3435T and G2677T gene polymorphism: impact on the risk of acute rejection in pediatric kidney transplant recipients.
    Korkor MS; El-Desoky T; Mosaad YM; Salah DM; Hammad A
    Ital J Pediatr; 2023 May; 49(1):57. PubMed ID: 37198710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.